Tinea barbae
ICD-10 B46.0 is a billable code used to indicate a diagnosis of tinea barbae.
Tinea barbae is a superficial fungal infection affecting the beard area, primarily caused by dermatophytes, particularly Trichophyton species. This condition is characterized by erythematous, scaly patches that may progress to pustules and crusting. It typically occurs in adult males who have facial hair, often linked to close contact with infected animals or individuals. The infection can present as pruritic lesions, and in some cases, it may lead to secondary bacterial infections due to scratching. Diagnosis is primarily clinical, supported by KOH examination or culture of the affected area. Treatment usually involves topical antifungals such as clotrimazole or terbinafine, but in more severe cases, systemic antifungal therapy may be necessary. Immunocompromised patients, including those with diabetes or HIV, are at higher risk for more extensive infections and may require aggressive treatment and monitoring. Proper hygiene and avoidance of sharing personal grooming items are essential preventive measures.
Detailed clinical notes including lesion description, treatment plan, and follow-up.
Patients presenting with itchy, scaly patches in the beard area.
Consideration of differential diagnoses such as folliculitis or psoriasis.
Comprehensive history of immunocompromised status and treatment response.
Immunocompromised patients with recurrent or severe tinea barbae.
Need for systemic antifungal therapy and monitoring for complications.
Used for follow-up visits to assess treatment response.
Document the patient's history, examination findings, and treatment plan.
Dermatologists may require more detailed skin examination notes.
Common treatments include topical antifungals like clotrimazole and terbinafine. In severe cases, systemic antifungals such as itraconazole or fluconazole may be prescribed, especially for immunocompromised patients.
